Publications by authors named "M Lejeune"

Claim this Profile
P
Pembrolizumab versus pembrolizumab plus chemotherapy in patients with PDL1 ⩾50% advanced non-small-cell lung cancer, depending on tumor aggressiveness and clinical impact.
Marine Lejeune, Eric Wasielewski, Vincent Leroy, Soraya Bordier, Arnaud Scherpereel

Ther Adv Med Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Faffa Malan Chart score is a poor single indicator for gastrointestinal parasitic burden of small ruminants in New York State.
Isabelle Louge, Manigandan Lejeune, Mathew Edwards, Mary Smith, Holly White

J Am Vet Med Assoc· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moose Survival and Habitat-Associated Risk of Endoparasites.
Jennifer A Grauer, Jacqueline L Frair, Krysten L Schuler, Manigandan Lejeune, David W Kramer

Ecol Evol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of the molecular subtype-dependent immune microenvironment of metastatic axillary lymph nodes on breast cancer patient outcomes.
Carlos López, Laia Reverté, Ramon Bosch Príncep, Esther Sauras, Noèlia Gallardo-Borràs, Marylène Lejeune

Pathobiology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histological Hyperspectral Breast Cancer Recurrence Database (HistologyHSI-BC Recurrence).
Laura Quintana-Quintana, Esther Sauras-Colón, Alessio Fiorin, Javier Santana-Nunez, Samuel Ortega, Marylène Lejeune

Sci Data· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis